Language selection

Search

Details for: GLEEVEC

Company: NOVARTIS PHARMACEUTICALS CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02253275GLEEVECIMATINIB (IMATINIB MESYLATE)100 MGTABLETORAL
02253283GLEEVECIMATINIB (IMATINIB MESYLATE)400 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Imatinib Mesylate (GLEEVEC and generics) - Assessing the Risk of Decline in Kidney Function During Long-Term Treatment
Summary Safety Review - Bcr-Abl Tyrosine Kinase Inhibitors - Assessing the Potential Harm to the Fetus
Summary Safety Review - Imatinib mesylate (GLEEVEC and generics) - Assessing the potential risk of tendon disorders

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: